MINDMAP*Cancer-Study: Mechanisms of psychological change during therapy for breast cancer: a multidimensional approach

Recruiting

• Conditions: C50; Malignant neoplasm of breast

• Registration Number: DRKS00031720
• Lead Sponsor: Klinik für Psychosomatik und Psychotherapie des UKSH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

suffient German language skills
infoment, written consent
acute initial diagnosis of breast cancer

Exclusion Criteria

any kind of dementia
lifetime diagnosis of a major psychotic disorder

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health related life satisfaction measured by self-rating questionnaire Short-Form-Health-Survey-12 (SF-12) particularly subscale mental health during oncological treatment over 40 weeks (T0-T11).

Secondary Outcome Measures

Name	Time	Method
Additional questionnaires assessing general anxiety using the Generalized Anxiety Disorder-7 (GAD-7), somatic symptoms using the Somatic Symptoms Disorder – B Criteria Scale-12, depressive symptoms using the Patient Health Questionnaire (PHQ-9) and impact of breast cancer treatment using FACT-B )Functional Assessment of Cancer Therapy) at (T0), T2, T4, T6, T8-11.<br>Assessments T0, T4, T8 and T11 also include a questionnaire about the satisfaction with the treatment (Client Satisfaction Questionnaire, CSQ-8). <br>Pyschological support for breast cancer will be assessed three at times.